Moxifloxacin hydrochloride - CAS:186826-86-8 Specificaton & Trade Terms
| Model | CAS:186826-86-8 |
|---|
| Place Of Origin | China |
|---|
| Price Term | EX-Work |
|---|
| Payment Term | T/T |
|---|
Moxifloxacin hydrochloride
Another Name:AVALOX;BAY-12-8039;(1's,6's)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride;1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO- 8-METHOXY-7- [(4AS,7AS)-OCTAHYDRO-6H-PYRROLO[3,4-B]PYRIDIN-6-YL]-4-OXO-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE;1-CYCLOPROPYL-7-[(S,S)-2,8-DIAZA-BICYCLO[4.3.0]NON-8-YL]-6-FLUORO-8-METHOXY-1,4-DIHYDRO-4-OXO-3-QUINOLINE CARBOXYLIC ACID HYDROCHLORIDE;ACTIRA;PROFLOX;MOXIFLOXACIN HCL
CAS:186826-86-8
Molecular Weight:437.89
Molecular Formula:C21H25ClFN3O4
Assay: 99%
Package: 25kg/carton
Appearance: White to light yellow crystalline powder.
Usage: an antibiotic used to treat bacterial infections in adult lung, paranasal sinus, skin, abdominal cavity. Can be used in the treatment of Staphylococcus aureus bacteria, Bacillus influenzae, pneumococcus, mucositis m?la Lactobacillus bacteria, pneumonia caused by community-acquired pneumonia, acute episode of chronic bronchitis, acute sinusitis, and so on.
